PA
OO

Onco360 Oncology Pharmacy

Nation's leading independent oncology specialty pharmacy delivering 24/7 expert dispensing and clinical support for complex cancer care.

Visit Website

Known For

100% oncology focus (not multi-disease), national network of accredited oncology pharmacies, Total Protocol Management® for oral/injectable/infusible protocols, top access to limited distribution d...

Overview

Onco360 is a specialty pharmacy 100% focused on oncology, dispensing oral, injected, and infused cancer therapies through a national network of accredited pharmacies. It provides comprehensive support including insurance verification, prior authorizations, financial assistance, patient counseling, and side effect management to streamline cancer care. Board-certified oncology pharmacists offer 24/7 access, with robust handling of limited distribution drugs.

Services & Capabilities

  • Specialty pharmacy dispensing (oral/injected/infused oncology meds, limited distribution), insurance benefit verification, prior authorization, billing, patient financial assistance sourcing, clinical counseling by BCOP pharmacists, side effect management, 24/7 patient support, digital tools (myOnco

Competitive Position

  • 100% oncology focus (not multi-disease), national network of accredited oncology pharmacies, Total Protocol Management® for oral/injectable/infusible protocols, top access to limited distribution drugs, #1 rated for patient/provider satisfaction.

Client & Partner Ecosystem

Rigel Pharmaceuticals (TAVALISSE, GAVRETO, REZLIDHIA), Corcept Therapeutics (LIFYORLI), Kura Oncology (Komzifti), SpringWorks Therapeutics (GOMEKLI), Regeneron (Lynozyfic); Pharma partners: BeiGene, Sun Pharma, SpringWorks Therapeutics, Nuvation Bio, Ba

Technology Platform

Total Protocol Management®; myOnco360 patient app/portal; Best-in-class tech/data reporting for patient journey; Enterprise Data Services

Therapeutic Focus

oncology

Target Customers

oncologists/HCPs, hospitals/health systems, payers, pharma manufacturers (as exclusive national pharmacy partner), patients

Sources